Page last updated: 2024-08-24

imiquimod and Facial Neoplasms

imiquimod has been researched along with Facial Neoplasms in 57 studies

Research

Studies (57)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	36 (63.16)	29.6817
2010's	20 (35.09)	24.3611
2020's	1 (1.75)	2.80

Authors

Authors	Studies
Dirschka, T; Gollnick, H; Kerl, H; Kunstfeld, R; Ostendorf, R	1
Corcoran, LM; Lyons, AB; Patchett, AL; Tovar, C; Woods, GM	1
Baz Morelli, A; Belov, K; Carver, S; Corcoran, LM; Fox, S; Hogg, CJ; Kreiss, A; Lyons, AB; McLennan, E; Patchett, A; Pearse, MJ; Pemberton, D; Pye, R; Silva, A; Thomson, R; Woods, GM	1
Alaibac, M; Ferranti, M; Tadiotto Cicogna, G; Vaccari, D	1
Bassukas, ID; Gaitanis, G	1
Bourgault-Villada, I; Clerici, T; Elfatoiki, FZ; Longvert, C; Roudier-Pujol, C; Saiag, P; Vasseur, E	1
Alarcon, I; Alos, L; Carrera, C; Malvehy, J; Palou, J; Puig, S	1
Hu, L; Huang, HZ; Li, W; Li, X; Lin, XX	1
Bassukas, ID; Gaitanis, G; Kalogeropoulos, CD	1
Barlow, R; Coleman, A; Craythorne, EE; Kai, AC; Mallipeddi, R; Richards, T	1
de Vries, K; Greveling, K; Prens, EP; van Doorn, MB	1
Darby, JM; Lyons, AB; Patchett, AL; Tovar, C; Woods, GM	1
Joseph, MG; Mahoney, MH; Temple, C	1
Aricò, M; Bongiorno, MR	1
Cintra, ML; de Souza, EM; Metze, K; Rybka, MO	1
Ramsdell, AM; Zeitouni, N	1
Barlow, RJ; Powell, AM; Robson, AM; Russell-Jones, R	1
Eickenscheidt, L; Kowalzick, L	1
McCall, MW; Woodmansee, CS	1
Brightman, L; Daniel, DR; Geronemus, RG; Mahlberg, MJ; Mintzis, MM; Sukal, SA	1
Kirtschig, G; Van Doorn, R; Van Meurs, T	1
Bassukas, ID; Gaitanis, G; Kalogeropoulos, C	1
Aguayo, R; Baradad, M; Casanova, JM; Sanmartín, V	1
Humphreys, TR; Rubenzik, MK; Schwartz, LR	1
Cohen, JL; Ellis, LZ; High, W; Stewart, L	1
Brand, E; Krekels, GA; Martens, J; Neumann, HA; Ostertag, JU; van der Geer, S; van Roij, J; Verhaegh, ME	1
Guillén, C; Llombart, B; Messeguer, F; Requena, C; Serra-Guillén, C	1
Cooper, A; Hong, E	1
Maatouk, I; Moutran, R; Stephan, F; Tomb, R	1
Altmeyer, P; Oster-Schmidt, C; Stücker, M	1
Brennick, JB; Chapman, MS; Spencer, SK	1
Epstein, E	1
Fisher, GH; Lang, PG	1
Borucki, U; Metze, D	1
Kossard, S	1
De'Ambrosis, B; Mirza, B	1
De Pasquale, R; Lacarrubba, F; Micali, G; Nasca, MR	1
Piérard, GE; Quatresooz, P	1
Roseeuw, D	1
Difonzo, EM; Giannotti, B; Pimpinelli, N; Vanzi, L	1
Barlow, RJ; Powell, AM; Russell-Jones, R	1
Astner, S; Curiel-Lewandrowski, C; Frankenthaler, RA; González, S; Swindells, KJ; Tahan, SR; Williams, CM	1
Braathen, LR; Brönnimann, M; Kappeler, A; Michalopoulos, P; Yawalkar, N	1
Bauer, J; Eigentler, TK; Garbe, C; Kamin, A; Radny, P; Weide, B	1
Grant-Kels, JM; Grin, CM; Kluk, M; Ray, CM	1
Lorentzen, HF; Weismann, K	1
Dalrymple, J; Hanger, C; Hepburn, D	1
Martín, T; Martínez, S; Ojeda, A; Vera, A	1
Mendonça, CO; Yates, VM	1
Martínez, MI; Mihm, MC; Sanchez-Carpintero, I	1
Siller, G; Vun, Y	1
Ho, NT; Lansang, P; Pope, E	1
Beltrani, V; Brennick, JB; Chapman, MS; Perry, AE; Spenny, ML; Storm, CA; Walford, J; Werchniak, AE	1
Bystryn, JC; Czernik, A	1
De Pasquale, R; Micali, G; Nasca, MR	1
Bichel, J; Carey-Yard, M; Sterry, W; Stockfleth, E	1
Varghese, M; Weisberg, NK	1

Reviews

1 review(s) available for imiquimod and Facial Neoplasms

Article	Year
Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials. Journal of the European Academy of Dermatology and Venereology : JEADV, 2020, Volume: 34, Issue:1 Topics: Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Diclofenac; Facial Neoplasms; Female; Gels; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Scalp; Skin Cream	2020

Article

Year

Long-term clinical outcomes of imiquimod 5% cream vs. diclofenac 3% gel for actinic keratosis on the face or scalp: a pooled analysis of two randomized controlled trials.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2020, Volume: 34, Issue:1

Topics: Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Diclofenac; Facial Neoplasms; Female; Gels; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Scalp; Skin Cream

2020

Trials

4 trial(s) available for imiquimod and Facial Neoplasms

Article	Year
Immunocryosurgery for non-superficial basal cell carcinoma: a pro-spective, open-label phase III study for tumours ≤ 2 cm in diameter. Acta dermato-venereologica, 2014, Volume: 94, Issue:1 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Facial Neoplasms; Feasibility Studies; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Treatment Failure; Tumor Burden	2014
Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma. Dermatology (Basel, Switzerland), 2015, Volume: 230, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Extremities; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Imiquimod; Infant; Male; Neoplastic Syndromes, Hereditary; Non-Randomized Controlled Trials as Topic; Ointments; Ophthalmic Solutions; Skin Neoplasms; Timolol; Torso	2015
Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study. The British journal of dermatology, 2012, Volume: 167, Issue:1 Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aminoquinolines; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Ointments; Preoperative Care; Prospective Studies; Skin Neoplasms; Treatment Outcome; Tumor Burden	2012
Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head. The British journal of dermatology, 2007, Volume: 157 Suppl 2 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Facial Neoplasms; Female; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Patient Compliance; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays	2007

Other Studies

52 other study(ies) available for imiquimod and Facial Neoplasms

Article	Year
The toll-like receptor ligands Hiltonol Developmental and comparative immunology, 2017, Volume: 76 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antigens; Cancer Vaccines; Carboxymethylcellulose Sodium; Cells, Cultured; Facial Neoplasms; Hemocyanins; Humans; Imiquimod; Immunity; Immunity, Innate; Immunization; Immunoglobulin G; Leukocytes, Mononuclear; Lymphocyte Activation; Marsupialia; Poly I-C; Polylysine; Toll-Like Receptors	2017
Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release. Frontiers in immunology, 2018, Volume: 9 Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; Carboxymethylcellulose Sodium; Facial Neoplasms; Female; Histocompatibility Antigens Class I; Imiquimod; Immunity, Humoral; Immunization, Secondary; Immunoglobulin G; Immunotherapy; Male; Marsupialia; Poly I-C; Polylysine; Tumor Escape	2018
Topical imiquimod-induced linear IgA bullous dermatosis. BMJ case reports, 2019, Jul-19, Volume: 12, Issue:7 Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Basal Cell; Dapsone; Facial Neoplasms; Female; Humans; Imiquimod; Linear IgA Bullous Dermatosis	2019
[In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery]. Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:2 Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Disease Progression; Electrocoagulation; Facial Neoplasms; Fatal Outcome; Humans; Imiquimod; Interferon-alpha; Laser Therapy; Lasers, Gas; Leg; Lymphatic Metastasis; Male; Melanoma; Palliative Care; Remission Induction; Sentinel Lymph Node Biopsy; Skin Neoplasms	2014
In vivo reflectance confocal microscopy to monitor the response of lentigo maligna to imiquimod. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:1 Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Aminoquinolines; Dermoscopy; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Off-Label Use; Prospective Studies; Skin Neoplasms	2014
Cryosurgery during Imiquimod (Immunocryosurgery) for Periocular Basal Cell Carcinomas: An Efficacious Minimally Invasive Treatment Alternative. Dermatology (Basel, Switzerland), 2016, Volume: 232, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Child; Combined Modality Therapy; Cryosurgery; Facial Neoplasms; Feasibility Studies; Female; Humans; Imiquimod; Male; Middle Aged; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Young Adult	2016
Five-year recurrence rate of lentigo maligna after treatment with imiquimod. The British journal of dermatology, 2016, Volume: 174, Issue:1 Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms	2016
A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose. The British journal of dermatology, 2016, Volume: 174, Issue:5 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Laser Therapy; Leg; Male; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms; Treatment Outcome	2016
The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines. PloS one, 2016, Volume: 11, Issue:12 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Apoptosis; Cell Line, Tumor; Facial Neoplasms; Humans; Imiquimod; Marsupialia; Skin Neoplasms	2016
Topical imiquimod therapy for lentigo maligna. Annals of plastic surgery, 2008, Volume: 61, Issue:4 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Skin Neoplasms	2008
Preliminary communication: imiquimod in mixed capillary/lymphatic malformation. Dermatologic therapy, 2008, Volume: 21 Suppl 2 Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Capillaries; Chin; Facial Neoplasms; Hemangioma; Humans; Imiquimod; Lymphatic Abnormalities; Lymphatic Vessels; Male	2008
Density of dendritic cells around basal cell carcinomas is related to tumor size, anatomical site and stromal characteristics, and might be responsible for the response to topical therapy. International journal of dermatology, 2008, Volume: 47, Issue:12 Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Count; Facial Neoplasms; Female; Humans; Imiquimod; Langerhans Cells; Male; Middle Aged; Skin Neoplasms	2008
Long-term follow-up of a hemifacial lentigo maligna treated using 5% imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:2 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Disease-Free Survival; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Remission Induction; Skin Neoplasms	2009
Imiquimod and lentigo maligna: a search for prognostic features in a clinicopathological study with long-term follow-up. The British journal of dermatology, 2009, Volume: 160, Issue:5 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Prognosis; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2009
Progress of multiple cutaneous and subcutaneous melanoma metastases of the face during imiquimod treatment. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2009, Volume: 7, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Fatal Outcome; Humans; Imiquimod; Male; Melanoma; Skin Neoplasms; Treatment Failure	2009
Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:8 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Skin Neoplasms	2009
What lies beneath? A lesson for the clinician. Intraoperative frozen section appearance of persistent basal cell carcinoma after apparent cure with imiquimod 5% cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2009, Volume: 35, Issue:11 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Frozen Sections; Humans; Imiquimod; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Ointments	2009
Treatment of lentigo maligna with imiquimod cream: a long-term follow-up study of 10 patients. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2010, Volume: 36, Issue:6 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Prospective Studies; Skin Neoplasms; Treatment Outcome	2010
Imiquimod can be combined with cryosurgery (immunocryosurgery) for locally advanced periocular basal cell carcinomas. The British journal of ophthalmology, 2011, Volume: 95, Issue:6 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Eyelid Neoplasms; Facial Neoplasms; Female; Humans; Imiquimod; Male; Nose Neoplasms	2011
[Oral acitretin and topical imiquimod as neoadjuvant treatment for giant basal cell carcinoma]. Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:2 Topics: Acitretin; Administration, Cutaneous; Administration, Oral; Aged; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Facial Neoplasms; Female; Humans; Imiquimod; Neoadjuvant Therapy; Psoriasis; Remission Induction; Skin Neoplasms; Skin Ulcer; Thoracic Neoplasms	2012
Large facial basal cell carcinoma treated with multimodal combination therapy. Cutis, 2011, Volume: 88, Issue:4 Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Combined Modality Therapy; Facial Neoplasms; Follow-Up Studies; Humans; Imiquimod; Male; Mohs Surgery; Skin Neoplasms; Treatment Outcome	2011
Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2012, Volume: 38, Issue:6 Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Facial Neoplasms; Follow-Up Studies; Humans; Imiquimod; Male; Melanoma; Mohs Surgery; Skin Neoplasms	2012
Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream. International journal of dermatology, 2012, Volume: 51, Issue:4 Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms	2012
Incipient retinal vein occlusion following immunotherapy of periorbital basal cell carcinoma. The Australasian journal of dermatology, 2012, Volume: 53, Issue:2 Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Middle Aged; Retinal Vein Occlusion; Skin Neoplasms	2012
Treatment of nodular basal cell carcinoma with cryotherapy and reduced protocol of imiquimod. Cutis, 2012, Volume: 90, Issue:5 Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryotherapy; Facial Neoplasms; Humans; Imiquimod; Male; Nose; Skin Neoplasms	2012
Successful treatment of basal cell carcinoma on the face with imiquimod 5% cream. Acta dermato-venereologica, 2002, Volume: 82, Issue:6 Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; Treatment Outcome	2002
Histologic resolution of melanoma in situ (lentigo maligna) with 5% imiquimod cream. Archives of dermatology, 2003, Volume: 139, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms	2003
Extensive lentigo maligna clearing with topical imiquimod. Archives of dermatology, 2003, Volume: 139, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms	2003
Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease. Archives of dermatology, 2003, Volume: 139, Issue:7 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Skin Neoplasms	2003
Topical treatment of lentigo maligna melanoma with imiquimod 5% cream. Dermatology (Basel, Switzerland), 2003, Volume: 207, Issue:3 Topics: Administration, Topical; Aged; Aminoquinolines; Dose-Response Relationship, Drug; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Ointments; Skin Neoplasms; Treatment Outcome	2003
Treatment of large facial Bowen's disease: case report. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Humans; Imiquimod; Ointments; Treatment Outcome	2003
Treatment of facial superficial basal cell carcinomas with imiquimod 5% cream. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Middle Aged; Ointments; Sunlight; Treatment Outcome	2003
The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms; Treatment Outcome	2003
Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Carcinoma, Basal Cell; Dendritic Cells; Facial Neoplasms; Factor XIIIa; Humans; Imiquimod; Immunohistochemistry; Middle Aged; Skin Neoplasms	2003
The treatment of basal skin carcinomas in two sisters with xeroderma pigmentosum. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Skin Neoplasms; Treatment Outcome; Xeroderma Pigmentosum	2003
The treatment of basal cell carcinomas in a patient with xeroderma pigmentosum with a combination of imiquimod 5% cream and oral acitretin. Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1 Topics: Acitretin; Administration, Oral; Administration, Topical; Adolescent; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Therapy, Combination; Facial Neoplasms; Humans; Imiquimod; Keratolytic Agents; Male; Treatment Outcome; Xeroderma Pigmentosum	2003
Topical imiquimod immunotherapy in the management of lentigo maligna. Clinical and experimental dermatology, 2004, Volume: 29, Issue:1 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunotherapy; Male; Skin Neoplasms; Treatment Outcome	2004
Use of in vivo confocal microscopy in malignant melanoma: an aid in diagnosis and assessment of surgical and nonsurgical therapeutic approaches. Archives of dermatology, 2004, Volume: 140, Issue:9 Topics: Aminoquinolines; Biopsy, Needle; Facial Neoplasms; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Melanoma; Microscopy, Confocal; Middle Aged; Mohs Surgery; Neoplasm Staging; Risk Assessment; Sampling Studies; Sensitivity and Specificity; Skin; Skin Neoplasms; Treatment Outcome	2004
Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod. The British journal of dermatology, 2004, Volume: 151, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Skin Neoplasms; T-Lymphocyte Subsets	2004
Imiquimod in the treatment of extensive recurrent lentigo maligna. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:2 Suppl 1 Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Recurrence, Local; Skin Neoplasms	2005
Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream. International journal of dermatology, 2005, Volume: 44, Issue:5 Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Facial Neoplasms; Female; Humans; Imiquimod; Male; Melanoma; Skin Neoplasms; Treatment Outcome	2005
[Imiquimod treatment of lentigo maligna to dermoscopic and histologic clearance]. Ugeskrift for laeger, 2005, Sep-26, Volume: 167, Issue:39 Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Cheek; Dermoscopy; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Ointments; Skin Neoplasms	2005
Systemic side effects from topical imiquimod. The New Zealand medical journal, 2005, Oct-07, Volume: 118, Issue:1223 Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Blood Sedimentation; Carcinoma, Basal Cell; Depression; Facial Neoplasms; Fatigue; Feeding and Eating Disorders; Humans; Hypotension, Orthostatic; Imiquimod; Male; Treatment Outcome; Weight Loss	2005
[Lentigo maligna treated with 5% imiquimod cream]. Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:10 Topics: Aminoquinolines; Antineoplastic Agents; Dosage Forms; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Remission Induction; Skin Neoplasms	2005
Permanent facial hypopigmentation following treatment with imiquimod cream. Clinical and experimental dermatology, 2006, Volume: 31, Issue:5 Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Humans; Hypopigmentation; Imiquimod; Male; Steroids; Treatment Outcome	2006
Clinical and histopathologic observations of the action of imiquimod in an epithelioid hemangioendothelioma and Paget's mammary disease. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:1 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Facial Neoplasms; Female; Hemangioendothelioma, Epithelioid; Humans; Imiquimod; Middle Aged; Paget's Disease, Mammary	2006
Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study. The Australasian journal of dermatology, 2006, Volume: 47, Issue:3 Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Facial Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Mucous Membrane; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2006
Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:1 Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Child, Preschool; Drug Eruptions; Facial Neoplasms; Female; Head and Neck Neoplasms; Hemangioma; Humans; Imiquimod; Infant; Infant, Newborn; Interferon Inducers; Male; Ointments; Remission Induction; Retrospective Studies; Severity of Illness Index; Skin Neoplasms; Treatment Outcome	2007
Lentigo maligna (melanoma in situ) treated with imiquimod cream 5%: 12 case reports. Cutis, 2007, Volume: 79, Issue:2 Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Ointments; Retrospective Studies; Skin Neoplasms; Treatment Outcome	2007
Does imiquimod work in infantile hemangiomas? Journal of the American Academy of Dermatology, 2007, Volume: 57, Issue:3 Topics: Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Head and Neck Neoplasms; Hemangioma; Humans; Imiquimod; Infant; Infant, Newborn	2007
Multiple and clustered eruptive epidermoid cysts following treatment with topical imiquimod. Dermatology (Basel, Switzerland), 2007, Volume: 215, Issue:4 Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Diagnosis, Differential; Epidermal Cyst; Facial Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Nose	2007
Therapeutic response of a brother and sister with xeroderma pigmentosum to imiquimod 5% cream. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2002, Volume: 28, Issue:6 Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Drug Tolerance; Facial Neoplasms; Female; Humans; Imiquimod; Male; Ointments; Skin Neoplasms; Xeroderma Pigmentosum	2002